Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information
This activity will review the latest PK recommendations for Factor VIII and IX replacement and how to use and interpret PK parameters to assess treatment plans.
Choose from the criteria below to find an activity that fits you best.
Original Broadcast Date: Tuesday, September 12, 2017
While much emphasis has been placed on the improvement of IV infusion safety, there remains a limited amount of standardized safe practices associated with IV push injection safety. This webinar will describe the latest changes in procedural and practice expectations and will educate participants about Institute for Safe Medication Practices (ISMP) guidelines for adult IV push medications, which were developed as a result of a national summit. Expert speakers will discuss strategies for identifying and managing the risks associated with IV push injection, including those associated with unsafe unit-based preparation, unsafe injection practices, and limited training and guidance.
The target audience for this activity includes Nurses, Pharmacists, Clinical educators, Pharmacy and nursing managers and administrators, Medication safety and patient safety officers, Risk and quality managers.
At the completion of this webinar, the participant will be able to:
Michael R. Cohen, RPh, MS, ScD (hon.), DPS (hon.), FASHP- President, ISMP
Push Medication Use: Understanding the Risk and Safety Challenges
Michelle Mandrack, MSN, RN Director of Consulting Services, ISMP
Advancing Medication Safety: ISMP Safe Practice Guidelines for Adult IV Push Medications
Susan Paparella, MSN, RN Vice President, ISMP
This non-accredited webinar is sponsored by Fresenius Kabi.
|Institute for Safe Medication Practices (ISMP)
200 Lakeside Drive, Suite 200, Horsham, PA 19044
Phone: (215) 947-7797 www.ismp.org
For registration questions, contact ProCE at 1-800-748-7795.
The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.